These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38275890)

  • 1. Tumor Suppression by Anti-Fibroblast Activation Protein Near-Infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts.
    Glabman RA; Olkowski CP; Minor HA; Bassel LL; Kedei N; Choyke PL; Sato N
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity.
    Akai M; Noma K; Kato T; Nishimura S; Matsumoto H; Kawasaki K; Kunitomo T; Kobayashi T; Nishiwaki N; Kashima H; Kikuchi S; Ohara T; Tazawa H; Choyke PL; Kobayashi H; Fujiwara T
    Br J Cancer; 2024 Jun; 130(10):1647-1658. PubMed ID: 38555315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer.
    Katsube R; Noma K; Ohara T; Nishiwaki N; Kobayashi T; Komoto S; Sato H; Kashima H; Kato T; Kikuchi S; Tazawa H; Kagawa S; Shirakawa Y; Kobayashi H; Fujiwara T
    Sci Rep; 2021 Jan; 11(1):1693. PubMed ID: 33462372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-targeted near-infrared photoimmunotherapy for esophageal cancer and cancer-associated fibroblasts in the tumor microenvironment.
    Sato H; Noma K; Ohara T; Kawasaki K; Akai M; Kobayashi T; Nishiwaki N; Narusaka T; Komoto S; Kashima H; Katsura Y; Kato T; Kikuchi S; Tazawa H; Kagawa S; Shirakawa Y; Kobayashi H; Fujiwara T
    Sci Rep; 2022 Nov; 12(1):20152. PubMed ID: 36418422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating near-infrared photoimmunotherapy for targeting fibroblast activation protein-α expressing cells in vitro and in vivo.
    Jin J; Barnett JD; Krishnamachary B; Mironchik Y; Luo CK; Kobayashi H; Bhujwalla ZM
    Cancer Sci; 2023 Jan; 114(1):236-246. PubMed ID: 36169301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near-infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Patient-Derived Xenografts Using a Humanized Anti-Fibroblast Activation Protein Antibody.
    Kobayashi T; Noma K; Nishimura S; Kato T; Nishiwaki N; Ohara T; Kunitomo T; Kawasaki K; Akai M; Komoto S; Kashima H; Kikuchi S; Tazawa H; Shirakawa Y; Choyke PL; Kobayashi H; Fujiwara T
    Mol Cancer Ther; 2024 Jul; 23(7):1031-1042. PubMed ID: 38638034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma.
    Watanabe S; Noma K; Ohara T; Kashima H; Sato H; Kato T; Urano S; Katsube R; Hashimoto Y; Tazawa H; Kagawa S; Shirakawa Y; Kobayashi H; Fujiwara T
    Cancer Biol Ther; 2019; 20(9):1234-1248. PubMed ID: 31185791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Nanocage Mediated Fibroblast-Activation Protein Targeted Photoimmunotherapy To Enhance Cytotoxic T Cell Infiltration and Tumor Control.
    Zhen Z; Tang W; Wang M; Zhou S; Wang H; Wu Z; Hao Z; Li Z; Liu L; Xie J
    Nano Lett; 2017 Feb; 17(2):862-869. PubMed ID: 28027646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response.
    Kato T; Fukushima H; Furusawa A; Okada R; Wakiyama H; Furumoto H; Okuyama S; Takao S; Choyke PL; Kobayashi H
    Oncoimmunology; 2022; 11(1):2152248. PubMed ID: 36465486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts.
    Kato T; Furusawa A; Okada R; Inagaki F; Wakiyama H; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2023 Jan; 22(1):75-88. PubMed ID: 36223542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of radiation-induced senescent cancer cells and stromal cells in vitro by near-infrared photoimmunotherapy.
    Suzuki M; Kobayashi H; Hara D; Hanaoka H
    Cancer Med; 2024 Jun; 13(12):e7381. PubMed ID: 38888415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers.
    Wakiyama H; Furusawa A; Okada R; Inagaki F; Kato T; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
    Cancer Immunol Immunother; 2022 Dec; 71(12):2869-2879. PubMed ID: 35445836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model.
    Furusawa A; Okada R; Inagaki F; Wakiyama H; Kato T; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
    Oncoimmunology; 2022; 11(1):2019922. PubMed ID: 35003897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models.
    Maruoka Y; Furusawa A; Okada R; Inagaki F; Fujimura D; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H
    Cancer Immunol Res; 2020 Mar; 8(3):345-355. PubMed ID: 31953245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
    Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
    Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody-Drug Conjugate Targeting Fibroblast Activation Protein.
    Gallant JP; Hintz HM; Gunaratne GS; Breneman MT; Recchia EE; West JL; Ott KL; Heninger E; Jackson AE; Luo NY; Rosenkrans ZT; Hernandez R; Zhao SG; Lang JM; Meimetis L; Kosoff D; LeBeau AM
    Cancer Res Commun; 2024 Jun; 4(6):1481-1494. PubMed ID: 38747612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials.
    Okada R; Furusawa A; Vermeer DW; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Spanos WC; Allen CT; Kobayashi H
    EBioMedicine; 2021 May; 67():103345. PubMed ID: 33933782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Effectiveness of IgG Antibody versus F(ab')
    Kato T; Okada R; Furusawa A; Wakiyama H; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
    Mol Pharm; 2022 Oct; 19(10):3600-3611. PubMed ID: 35759343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel Therapy Targeting the Cancer Microenvironment Using Near-Infrared Photoimmunotherapy Leading to Tumor Immune Activation].
    Kato T; Noma K; Furusawa A; Kobayashi H; Fujiwara T
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1361-1363. PubMed ID: 38303275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
    Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
    World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.